The heart in scleroderma.

Suppr

超能文献

作者信息

ORAM S, STOKES W

出版信息

Br Heart J. 1961 May;23(3):243-59. doi: 10.1136/hrt.23.3.243.

DOI:10.1136/hrt.23.3.243

PMID:13731087

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1017763/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d679/1017763/e00e27bbf65a/brheartj00362-0026-a.jpg

相似文献

The heart in scleroderma.

Br Heart J. 1961 May;23(3):243-59. doi: 10.1136/hrt.23.3.243.

[Lesions of the heart in systemic scleroderma].

Ter Arkh. 1960 Feb;32:30-8.

Early cardiac connective tissue changes in scleroderma; report of a case.

Acta Med Scand. 1957 Feb 2;156(6):487-91. doi: 10.1111/j.0954-6820.1957.tb00106.x.

Cardiopulmonary changes in scleroderma. A physiologic study.

Am Heart J. 1961 Apr;61:494-9. doi: 10.1016/0002-8703(61)90548-8.

[The sclerodermal heart].

Coeur Med Interne. 1962 Apr;1:185-92.

[A CASE OF FATAL SYSTEMIC SCLERODERMA WITH LESIONS OF THE ENDOCARDIUM AND MYOCARDIUM].

J Med Lyon. 1964 Dec 20;45:2161-3.

[Factors influencing localization in circumscribed scleroderma].

Borgyogy Venerol Sz. 1958 Feb-Apr;12(1-2):60-6.

[Scleroderma].

Arch Belg Dermatol Syphiligr. 1951 Sep;7(3):150-1.

Scleroderma.

Proc R Soc Med. 1956 Apr;49(4):236. doi: 10.1177/003591575604900414.

[Scleroderma].

Presse Med (1893). 1953 Mar 18;61(19):387-8.

引用本文的文献

Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication.

J Rheumatol. 2021 Jul;48(7):1047-1052. doi: 10.3899/jrheum.201005. Epub 2021 Jan 15.

Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management.

Biomed Res Int. 2018 Jun 4;2018:6812082. doi: 10.1155/2018/6812082. eCollection 2018.

Autoimmune myocarditis in systemic sclerosis: an unusual form of scleroderma heart disease presentation.

ESC Heart Fail. 2017 Aug;4(3):365-370. doi: 10.1002/ehf2.12139. Epub 2017 Apr 22.

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice.

J Vis Exp. 2017 Mar 24(121):55036. doi: 10.3791/55036.

An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice.

PLoS One. 2016 Apr 6;11(4):e0151999. doi: 10.1371/journal.pone.0151999. eCollection 2016.

Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report.

J Med Case Rep. 2015 Jun 10;9:136. doi: 10.1186/s13256-015-0587-7.

Cardiac manifestations in systemic sclerosis.

World J Cardiol. 2014 Sep 26;6(9):993-1005. doi: 10.4330/wjc.v6.i9.993.

Cardiac involvement in patients of systemic sclerosis.

Indian J Dermatol. 2008;53(4):215-6. doi: 10.4103/0019-5154.44801.

Progressive systemic sclerosis with complete heart block.

Br Heart J. 1975 Dec;37(12):1308-10. doi: 10.1136/hrt.37.12.1308.

The heart in scleroderma.

Rheum Dis Clin North Am. 2008 Feb;34(1):181-90; viii. doi: 10.1016/j.rdc.2007.12.002.

本文引用的文献

Sclerodermia with Hypertension.

Proc R Soc Med. 1938 Jun;31(8):869-70. doi: 10.1177/003591573803100801.

Sclerodermia with Myositis Fibrosa.

Proc R Soc Med. 1912;5(Sect Study Dis Child):6-7. doi: 10.1177/003591571200501504.

Pathology of Scleroderma, with Special Reference to the Changes in the Gastrointestinal Tract.

Am J Pathol. 1945 Jan;21(1):25-51.

THE HEART IN SCLERODERMA.

Br Heart J. 1947 Jul;9(3):167-74. doi: 10.1136/hrt.9.3.167.

The pulmonary manifestations of scleroderma; an anatomic-physiological correlation.

Ann Intern Med. 1950 Jan;32(1):152-61, illust. doi: 10.7326/0003-4819-32-1-152.

The kidney of scleroderma.

Lancet. 1952 Jan 12;1(6698):68-70. doi: 10.1016/s0140-6736(52)91798-4.

Scleroderma heart disease.

Am Heart J. 1951 Nov;42(5):758-65. doi: 10.1016/0002-8703(51)90182-2.

Cortisone and corticotropin (ACTH) in dermatology.

J Am Med Assoc. 1951 Jan 5;145(1):23-6. doi: 10.1001/jama.1952.02930010025005.

Clinical study of visceral lesions and endocrine disturbances in eight cases of diffuse scleroderma.

Ann Intern Med. 1951 Apr;34(4):862-71. doi: 10.7326/0003-4819-34-4-862.

Cortisone-treated scleroderma; report of a case with autopsy findings.

J Am Med Assoc. 1951 Apr 21;145(16):1230-2. doi: 10.1001/jama.1951.02920340008003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The heart in scleroderma.

Br Heart J. 1961 May;23(3):243-59. doi: 10.1136/hrt.23.3.243.

[Lesions of the heart in systemic scleroderma].

Ter Arkh. 1960 Feb;32:30-8.

Early cardiac connective tissue changes in scleroderma; report of a case.

Acta Med Scand. 1957 Feb 2;156(6):487-91. doi: 10.1111/j.0954-6820.1957.tb00106.x.

Cardiopulmonary changes in scleroderma. A physiologic study.

Am Heart J. 1961 Apr;61:494-9. doi: 10.1016/0002-8703(61)90548-8.

[The sclerodermal heart].

Coeur Med Interne. 1962 Apr;1:185-92.

[A CASE OF FATAL SYSTEMIC SCLERODERMA WITH LESIONS OF THE ENDOCARDIUM AND MYOCARDIUM].

J Med Lyon. 1964 Dec 20;45:2161-3.

[Factors influencing localization in circumscribed scleroderma].

Borgyogy Venerol Sz. 1958 Feb-Apr;12(1-2):60-6.

[Scleroderma].

Arch Belg Dermatol Syphiligr. 1951 Sep;7(3):150-1.

Scleroderma.

Proc R Soc Med. 1956 Apr;49(4):236. doi: 10.1177/003591575604900414.

[Scleroderma].

Presse Med (1893). 1953 Mar 18;61(19):387-8.

引用本文的文献

Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication.

J Rheumatol. 2021 Jul;48(7):1047-1052. doi: 10.3899/jrheum.201005. Epub 2021 Jan 15.

Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management.

Biomed Res Int. 2018 Jun 4;2018:6812082. doi: 10.1155/2018/6812082. eCollection 2018.

Autoimmune myocarditis in systemic sclerosis: an unusual form of scleroderma heart disease presentation.

ESC Heart Fail. 2017 Aug;4(3):365-370. doi: 10.1002/ehf2.12139. Epub 2017 Apr 22.

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice.

J Vis Exp. 2017 Mar 24(121):55036. doi: 10.3791/55036.

An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice.

PLoS One. 2016 Apr 6;11(4):e0151999. doi: 10.1371/journal.pone.0151999. eCollection 2016.

Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report.

J Med Case Rep. 2015 Jun 10;9:136. doi: 10.1186/s13256-015-0587-7.

Cardiac manifestations in systemic sclerosis.

World J Cardiol. 2014 Sep 26;6(9):993-1005. doi: 10.4330/wjc.v6.i9.993.

Cardiac involvement in patients of systemic sclerosis.

Indian J Dermatol. 2008;53(4):215-6. doi: 10.4103/0019-5154.44801.

Progressive systemic sclerosis with complete heart block.

Br Heart J. 1975 Dec;37(12):1308-10. doi: 10.1136/hrt.37.12.1308.

The heart in scleroderma.

Rheum Dis Clin North Am. 2008 Feb;34(1):181-90; viii. doi: 10.1016/j.rdc.2007.12.002.

本文引用的文献

Sclerodermia with Hypertension.

Proc R Soc Med. 1938 Jun;31(8):869-70. doi: 10.1177/003591573803100801.

Sclerodermia with Myositis Fibrosa.

Proc R Soc Med. 1912;5(Sect Study Dis Child):6-7. doi: 10.1177/003591571200501504.

Pathology of Scleroderma, with Special Reference to the Changes in the Gastrointestinal Tract.

Am J Pathol. 1945 Jan;21(1):25-51.

THE HEART IN SCLERODERMA.

Br Heart J. 1947 Jul;9(3):167-74. doi: 10.1136/hrt.9.3.167.

The pulmonary manifestations of scleroderma; an anatomic-physiological correlation.

Ann Intern Med. 1950 Jan;32(1):152-61, illust. doi: 10.7326/0003-4819-32-1-152.

The kidney of scleroderma.

Lancet. 1952 Jan 12;1(6698):68-70. doi: 10.1016/s0140-6736(52)91798-4.

Scleroderma heart disease.

Am Heart J. 1951 Nov;42(5):758-65. doi: 10.1016/0002-8703(51)90182-2.

Cortisone and corticotropin (ACTH) in dermatology.

J Am Med Assoc. 1951 Jan 5;145(1):23-6. doi: 10.1001/jama.1952.02930010025005.

Clinical study of visceral lesions and endocrine disturbances in eight cases of diffuse scleroderma.

Ann Intern Med. 1951 Apr;34(4):862-71. doi: 10.7326/0003-4819-34-4-862.

Cortisone-treated scleroderma; report of a case with autopsy findings.

J Am Med Assoc. 1951 Apr 21;145(16):1230-2. doi: 10.1001/jama.1951.02920340008003.